Friday, April 24, 2026 | 05:20 AM ISTहिंदी में पढें
Pharmaids Pharmaceuticals Ltd
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)
02:20 PM, 27th Apr 2023
Pursuant to Regulation 32 of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24 2019 please note that there are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Preferential Issue of the Company during the third quarter ended December 31 2022.